| 34 |
LXR activation leading to hepatic steatosis |
Agnes Aggy |
BY-SA |
2 MIEs
|
345: N/A, Liver Steatosis
|
|
|
| 35 |
Narcosis leading to respiratory failure |
Allie Always |
BY-SA |
46: Accumulation, Biological membranes
|
None
|
Under Development |
1.2 |
| 36 |
Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis |
Evgeniia Kazymova |
BY-SA |
3 MIEs
|
459: Increased, Liver Steatosis
|
|
|
| 37 |
PPARα activation leading to hepatocellular adenomas and carcinomas in rodents |
Cataia Ives |
BY-SA |
227: Activation, PPARα
|
719: Increase, hepatocellular adenomas and carcinomas
|
Under Development |
1.17 |
| 38 |
Protein Alkylation leading to Liver Fibrosis |
Brendan Ferreri-Hanberry |
BY-SA |
244: Alkylation, Protein
|
344: N/A, Liver fibrosis
|
WPHA/WNT Endorsed |
1.14 |
| 39 |
Covalent Binding, Protein, leading to Increase, Allergic Respiratory Hypersensitivity Response |
Arthur Author |
BY-SA |
396: Covalent Binding, Protein
|
313: Increase, Allergic Respiratory Hypersensitivity Response
|
Under Development |
1.20 |
| 40 |
Covalent Protein binding leading to Skin Sensitisation |
Agnes Aggy |
BY-SA |
396: Covalent Binding, Protein
|
827: sensitisation, skin
|
WPHA/WNT Endorsed |
1.1 |
| 41 |
Sustained AhR Activation leading to Rodent Liver Tumours |
Allie Always |
BY-SA |
165: Activation, Long term AHR receptor driven direct and indirect gene expression changes
|
856: Formation, Hepatocellular and Bile duct tumors
|
Under Review |
1.7 |
| 42 |
Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals |
Evgeniia Kazymova |
BY-SA |
279: Thyroperoxidase, Inhibition
|
402: Cognitive function, decreased
|
WPHA/WNT Endorsed |
1.10 |
| 43 |
Disruption of VEGFR Signaling Leading to Developmental Defects |
Cataia Ives |
BY-SA |
305: Inhibition, VegfR2
|
1001: Increased, Developmental Defects
|
WPHA/WNT Endorsed |
1.6 |
| 46 |
AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC) |
Agnes Aggy |
BY-SA |
373: Formation, Pro-mutagenic DNA Adducts
|
378: Tumorigenesis, Hepatocellular carcinoma
|
Under Review |
1.8 |
| 48 |
Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment. |
Allie Always |
BY-SA |
875: Binding of agonist, Ionotropic glutamate receptors
|
341: Impairment, Learning and memory
|
WPHA/WNT Endorsed |
1.23 |
| 51 |
PPARα activation leading to impaired fertility in adult male rodents |
Evgeniia Kazymova |
BY-SA |
227: Activation, PPARα
|
406: decreased, Fertility
|
Under Development |
1.21 |
| 52 |
ER agonism leading to skewed sex ratios due to altered sexual differentiation in males |
Cataia Ives |
BY-SA |
111: Agonism, Estrogen receptor
|
417: skewed, sex ratio
|
|
|
| 53 |
ER agonism leading to reduced survival due to renal failure |
Brendan Ferreri-Hanberry |
BY-SA |
111: Agonism, Estrogen receptor
|
None
|
|
|
| 54 |
Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment |
Arthur Author |
BY-SA |
424: Inhibition, Na+/I- symporter (NIS)
|
341: Impairment, Learning and memory
|
WPHA/WNT Endorsed |
1.28 |
| 57 |
AhR activation leading to hepatic steatosis |
Agnes Aggy |
BY-SA |
18: Activation, AhR
|
459: Increased, Liver Steatosis
|
|
|
| 58 |
NR1I3 (CAR) suppression leading to hepatic steatosis |
Allie Always |
BY-SA |
4 MIEs
|
459: Increased, Liver Steatosis
|
|
|
| 59 |
HNF4alpha suppression leading to hepatic steatosis |
Evgeniia Kazymova |
BY-SA |
461: Suppression, HNF4alpha
|
None
|
|
|
| 60 |
NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis |
Cataia Ives |
BY-SA |
245: Activation, PXR/SXR
|
459: Increased, Liver Steatosis
|
|
|
| 61 |
NFE2L2/FXR activation leading to hepatic steatosis |
Brendan Ferreri-Hanberry |
BY-SA |
2 MIEs
|
459: Increased, Liver Steatosis
|
|
|
| 62 |
AKT2 activation leading to hepatic steatosis |
Arthur Author |
BY-SA |
486: systemic inflammation leading to hepatic steatosis
|
459: Increased, Liver Steatosis
|
|
|
| 63 |
Cyclooxygenase inhibition leading to reproductive dysfunction |
Agnes Aggy |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
2 AOs
|
|
|
| 64 |
Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility |
Allie Always |
BY-SA |
494: Glucocorticoid Receptor Agonist, Activation
|
406: decreased, Fertility
|
|
|
| 66 |
Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis |
Cataia Ives |
BY-SA |
2 MIEs
|
505: Decreased sperm quantity / quality in the adult, Decreased fertility
|
|
|